XLO
NASDAQ
$8.57
Xilio Therapeutics Inc (XLO)
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune systems of cancer patients. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Target: $20 (+133.37%)
Market Cap
$53M
P/B Ratio
0.84
Beta (5Y)
0.78
Price Chart
Valuation
Market Cap$53M
P/S1.14
P/B0.84
Profitability
Total Revenue (TTM)$53M
Gross Profit (TTM)$42M
EBITDA-$41M
Profit Margin-75.3%
Operating Margin-111.6%
EPS-$8.04
Growth & Risk
Beta (5Y)0.78
Sharpe Ratio-0.21